| ViiV Healthcare GmbH - Triumeq, Tabletten zur Herstellung einer Suspension zum Einnehmen | | 68920 | | 01 | | Triumeq | | Tabletten zur Herstellung einer Suspension zum Einnehmen | | J05AR13 | | Lamivudine, Abacavir and Dolutegravir | | 24.08.2023 | | |
| | Composition | | dolutegravirum 5 mg ut dolutegravirum natricum, abacavirum 60 mg ut abacaviri sulfas, lamivudinum 30 mg, mannitolum, cellulosum microcristallinum, povidonum K 29-32, carboxymethylamylum natricum A, cellulosum microcristallinum silicificatum, crospovidonum, acesulfamum kalicum, sucralosum, natrii stearylis fumaras, aromatica Erdbeercrèmearoma, Überzug: talcum, macrogolum 4000, poly(alcohol vinylicus), E 171, E 172 (flavum), pro compresso obducto corresp. natrium 0.9 mg. | | Packungsbestandteile | | | | | | Active Agent | Dose |
|---|
| Abacavir | 60 mg | | | 5 mg | | Lamivudine | 30 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | Acesulfamum Kalicum | | | | | | | | | | | | | | | | | | | | | | | | | | color. | | | | color. | | Macrogol | 4000 | | | Mannitol | | | | | | | | | | | | | 29-32 | | | | | | | | | | | Talcum | | Überzug |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 90 | PR | PR | A | | No |
|
|
